IRIS
CANTARINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.344
EU - Europa 17.554
AS - Asia 2.176
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 16
AF - Africa 13
Totale 40.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.308
GB - Regno Unito 6.969
IE - Irlanda 3.007
IT - Italia 2.152
CN - Cina 1.729
UA - Ucraina 1.607
SE - Svezia 1.367
FR - Francia 876
DE - Germania 765
FI - Finlandia 514
VN - Vietnam 162
TR - Turchia 73
ES - Italia 55
IN - India 53
PL - Polonia 51
BE - Belgio 50
JP - Giappone 44
CA - Canada 31
NL - Olanda 31
RU - Federazione Russa 31
AU - Australia 28
IR - Iran 26
PK - Pakistan 21
HK - Hong Kong 20
EU - Europa 16
CH - Svizzera 15
GR - Grecia 7
MK - Macedonia 7
BR - Brasile 6
CL - Cile 6
DK - Danimarca 6
EE - Estonia 6
PT - Portogallo 6
RO - Romania 6
BG - Bulgaria 5
EG - Egitto 5
ID - Indonesia 5
KR - Corea 5
MA - Marocco 5
SG - Singapore 5
BD - Bangladesh 4
CY - Cipro 4
HU - Ungheria 4
PH - Filippine 4
AT - Austria 3
MY - Malesia 3
NZ - Nuova Zelanda 3
AL - Albania 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
IQ - Iraq 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MX - Messico 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MM - Myanmar 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 40.150
Salva come PNG Salva come JPEG
Città #
Southend 6.692
Fairfield 3.332
Dublin 2.963
Ashburn 1.745
Chandler 1.721
Woodbridge 1.578
Wilmington 1.347
Jacksonville 1.313
Houston 1.301
Seattle 1.250
Cambridge 1.124
Ann Arbor 841
Menlo Park 653
Siena 637
Princeton 536
Nanjing 450
Beijing 335
Helsinki 275
New York 249
Boardman 235
San Mateo 232
San Diego 198
Dong Ket 161
Nanchang 141
Düsseldorf 127
Shenyang 118
Florence 105
Milan 103
Dearborn 99
Rome 80
Shanghai 72
Tianjin 70
Hebei 68
Washington 67
Jiaxing 66
London 65
Changsha 61
Izmir 51
Jinan 51
Venezia 51
Kunming 50
Málaga 49
Norwalk 49
Brussels 44
Kraków 38
Fremont 36
Redwood City 34
Guangzhou 33
Zhengzhou 30
Los Angeles 29
San Francisco 28
Lancaster 25
Bologna 23
Hangzhou 23
Tappahannock 22
Taizhou 21
Toronto 21
Falls Church 20
Changchun 19
Chicago 19
Lanzhou 19
Ningbo 19
Catania 15
Paris 15
Naples 14
Padova 14
Frankfurt am Main 13
Saint Petersburg 13
Cecina 12
Hounslow 12
Uzzano 12
Aachen 11
Bari 11
Chianciano Terme 11
Renton 11
Turin 11
Asciano 10
Comun Nuovo 10
Hyderabad 10
Livorno 10
Zanjan 10
Brescia 9
Carrara 9
Salerno 9
Sutri 9
Verona 9
Hefei 8
Lahore 8
Mcallen 8
Melbourne 8
Palermo 8
Prescot 8
Shinchiba 8
Amsterdam 7
Campi Bisenzio 7
Duncan 7
Falkenstein 7
Fuzhou 7
Groningen 7
Monza 7
Totale 31.589
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 284
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 255
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 246
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 238
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 222
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 212
Antiangiogenic VEGF isoform in inflammatory myopathies 211
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 203
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 199
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 194
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 192
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 192
Weekly oral alendronate in mevalonate kinase deficiency. 187
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 186
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 186
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 185
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 184
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 181
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 181
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 180
Antirheumatic agents in covid-19: is IL-6 the right target? 180
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 179
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 176
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 176
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 176
Peripheral biomarkers' panel for severe COVID-19 patients 176
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 174
Colchicine myopathy and neuromyopathy: two cases with different characteristics 174
Genetic mechanisms of critical illness in COVID-19 171
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations 170
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 170
null 170
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 169
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 167
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 166
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. 165
Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. 165
Working the endless puzzle of hereditary autoinflammatory disorders. 164
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 164
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 163
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 163
Recommendations for the management of autoinflammatory diseases 159
Untangling the Web of Systemic Autoinflammatory Diseases 157
Kawasaki syndrome and concurrent Coxsackie virus B3 infection 157
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 157
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 156
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 154
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 152
Autoinflammatory disorders and patients with isolated serosal involvement. 151
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 151
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 151
null 150
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 150
Short- and long-term effects of spa therapy in knee osteoarthritis. 148
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 148
IL-6 blockade in the management of non-infectious uveitis 148
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 148
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 147
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 146
Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene 145
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 145
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 145
Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings 145
Glucocorticoids in the management of systemic juvenile idiopathic arthritis 145
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 143
The hereditary autoinflammatory disorders uncovered 143
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 143
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 143
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 141
Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases 141
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 141
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 140
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease. 139
Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature 139
Tumour necrosis factor receptor-associated periodic syndrome(TRAPS): State of the art and future perspectives. 138
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 137
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease 137
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 137
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. 137
null 136
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 136
null 136
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 136
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis 135
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 135
Efficacy of alendronate in the treatment of the SAPHO syndrome. 135
null 134
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 133
Monogenic autoinflammatory syndromes at a dermatological level 133
null 133
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 133
Clinical and biochemical landmarks in systemic autoinflammatory diseases 132
Biological treatments in Behçet's disease: beyond anti-TNF therapy 132
Tocilizumab-induced exacerbation of mucosal ulcers in a patient with multi-refractory Behçet's disease 132
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review 132
Effects of Spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis 131
Possible chondroprotective effect of canakinumab: an in vitro study on human osteoarthritic chondrocytes 131
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 131
null 131
Clinical Characteristics of Patients Carrying the Q703K Variant of the NLRP3 Gene: A 10-year Multicentric National Study 131
Totale 16.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.016
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.644 0 0 0 0 0 0 0 0 0 518 1.049 1.077
2019/20208.528 981 361 570 1.257 458 779 697 1.022 830 776 283 514
2020/20216.819 411 746 218 681 428 992 276 985 409 587 454 632
2021/20225.095 494 562 335 331 285 186 230 209 369 626 512 956
2022/20236.340 414 424 735 896 625 1.267 247 514 677 140 246 155
2023/20244.795 240 165 496 286 237 1.371 1.581 217 44 158 0 0
Totale 41.164